Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects
NCT01856647 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2015-12-21
Summary
Obesity is an insulin resistance-associated metabolic disorder which is a hallmark of and risk factor for type 2 diabetes and the metabolic syndrome, often linked to cardiovascular disease, certain cancers and inflammatory diseases.The phenotyping of subcutaneous adipose tissue (SAT) hematopoetic cells from obese subjects by flow cytometry, microscopy and gene expression will enable us to identify inflammation in this tissue and may help us to understand the causes and consequences of obesity in order to determine how these cells might be implicated in the initiation and/or progression of the aforementioned diseases.
Conditions
Interventions
- PROCEDURE
-
Adipose tissue biopsy (fat biopsy)
An adipose tissue biopsy will be performed after a 10-12 hour overnight fast. A small sample of fat tissue will be removed from the subject for gene expression analysis. A subcutaneous fat biopsy (\~3 ml) will be obtained from the lower abdomen following local anesthesia.
Sponsors & Collaborators
-
Rockefeller University
lead OTHER
Principal Investigators
-
Juana Gonzalez · Rockefeller Univesrity
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of LY3532226 in Participants With Obesity
NCT06557356 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
NCT01853397 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
NCT04699669 ·Status: COMPLETED ·Phase: PHASE1
-
Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6
NCT04687540 ·Status: COMPLETED ·Phase: NA
-
Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
NCT07031297 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
NCT04698642 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of LLF580 in Obese Volunteers
NCT03466203 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
NCT04897412 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05841238 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects
NCT05943886 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
NCT01133210 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label Study That Will Test a Second Treatment Session of RZL-012.
NCT05763160 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05313802 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
NCT05632926 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
NCT01180465 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
NCT06628362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.
NCT05466448 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.
NCT06891287 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of LY3457263 in Obese Participants
NCT05582096 ·Status: COMPLETED ·Phase: PHASE1
-
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859 ·Status: COMPLETED ·Phase: PHASE3
-
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
NCT05653258 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
NCT06934408 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
NCT07030868 ·Status: TERMINATED ·Phase: PHASE2
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1